Literature DB >> 28597206

Effect of strut distribution on neointimal coverage of everolimus-eluting bioresorbable scaffolds: an optical coherence tomography study.

Takao Sato1,2, John Jose1,3, Abdelhakim Allai1, Mohamed El-Mawardy1, Ralph Tölg1, Gert Richardt1, Mohamed Abdel-Wahab4.   

Abstract

The thick struts of bioresorbable vascular scaffolds (BRS) are associated with changes in wall shear stress and contribute to neointimal proliferation. We aimed to evaluate the relationship between the BRS strut distribution and the neointimal proliferation. 50 lesions underwent optical coherence tomography, 12 months after BRS implantation. Scaffold area and neointimal thickness were evaluated in each cross-sectional area (CSA). Scaffold eccentricity was defined as follows: (maximum diameter - minimum diameter) × 100/maximum diameter. CSAs of BRS were divided into four quadrants. The maximal neointimal thickness (Maximal-NIT), Minimal-NIT and the number of struts in each quadrant were measured. The number of struts were classified as 1, 2, 3 and ≥ 4. Furthermore, the mean-NIT acquired in each quadrant was divided by the average-NIT of all struts in the same CSA, which was defined as the unevenness score. In addition, Maximal-NIT minus Minimal-NIT was divided by the average-NIT of all struts in the same CSA, which was defined as heterogenicity of neointimal proliferation. There was a significant difference in the association between the number of struts and not only the unevenness score (no. of strut = 1 (N = 440), unevenness score 1.04 ± 0.34; 2 (N = 696), 0.98 ± 0.27; 3 (N = 994), 0.96 ± 0.23; ≥4 (N = 1202), 1.04 ± 0.22, P < 0.01) but also Maximal-NIT and Minimal-NIT. Furthermore, a significant correlation was observed between scaffold eccentricity in each CSA and the heterogeneity of neointimal proliferation in the same CSA (N = 892, R = 0.38, p = 0.01). Crowding of struts is associated with increased neointimal proliferation after BRS implantation. The scaffold eccentricity causes heterogeneity of neointimal proliferation.

Entities:  

Keywords:  Bioresorbable vascular scaffolds; Neointimal proliferation; Optical coherence tomography

Mesh:

Substances:

Year:  2017        PMID: 28597206     DOI: 10.1007/s11239-017-1511-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  32 in total

1.  Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment.

Authors:  Tomohiko Teramoto; Fumiaki Ikeno; Hiromasa Otake; Jennifer K Lyons; Heleen M M van Beusekom; William F Fearon; Alan C Yeung
Journal:  Circ J       Date:  2010-04-29       Impact factor: 2.993

2.  Predictors of stent strut malapposition in calcified vessels using frequency-domain optical coherence tomography.

Authors:  Alistair C Lindsay; Manuel Paulo; Kilickesmez Kadriye; Rodrigo Tejeiro; Eduardo Alegría-Barrero; Pak Hei Chan; Nicolas Foin; Dimitris Syrseloudis; Carlo Di Mario
Journal:  J Invasive Cardiol       Date:  2013-09       Impact factor: 2.022

3.  Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.

Authors:  Yoshinobu Onuma; Patrick W Serruys; Laura E L Perkins; Takayuki Okamura; Nieves Gonzalo; Hector M García-García; Evelyn Regar; Marika Kamberi; Jennifer C Powers; Richard Rapoza; Heleen van Beusekom; Willem van der Giessen; Renu Virmani
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

4.  The sheer stress of straightening the curves: biomechanics of bioabsorbable stents.

Authors:  Michael C McDaniel; Habib Samady
Journal:  JACC Cardiovasc Interv       Date:  2011-07       Impact factor: 11.195

5.  Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.

Authors:  Akihito Tanaka; Richard J Jabbour; Azeem Latib; Antonio Colombo
Journal:  Catheter Cardiovasc Interv       Date:  2016-11       Impact factor: 2.692

6.  Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.

Authors:  Aloke V Finn; Frank D Kolodgie; Jan Harnek; L J Guerrero; Eduardo Acampado; Kirubel Tefera; Kristi Skorija; Deena K Weber; Herman K Gold; Renu Virmani
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

7.  Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries.

Authors:  J J Wentzel; R Krams; J C Schuurbiers; J A Oomen; J Kloet; W J van Der Giessen; P W Serruys; C J Slager
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

8.  Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin.

Authors:  T L Lambert; V Dev; E Rechavia; J S Forrester; F Litvack; N L Eigler
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

9.  The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.

Authors:  Pannipa Suwannasom; Yohei Sotomi; Yuki Ishibashi; Rafael Cavalcante; Felipe N Albuquerque; Carlos Macaya; John A Ormiston; Jonathan Hill; Irene M Lang; Mohaned Egred; Jean Fajadet; Maciej Lesiak; Jan G Tijssen; Joanna J Wykrzykowska; Robbert J de Winter; Bernard Chevalier; Patrick W Serruys; Yoshinobu Onuma
Journal:  JACC Cardiovasc Interv       Date:  2016-06-01       Impact factor: 11.195

10.  Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.

Authors:  Christos V Bourantas; Michail I Papafaklis; Anna Kotsia; Vasim Farooq; Takashi Muramatsu; Josep Gomez-Lara; Yao-Jun Zhang; Javaid Iqbal; Fanis G Kalatzis; Katerina K Naka; Dimitrios I Fotiadis; Cecile Dorange; Jin Wang; Richard Rapoza; Hector M Garcia-Garcia; Yoshinobu Onuma; Lampros K Michalis; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2014-02-13       Impact factor: 11.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.